294 related articles for article (PubMed ID: 25954204)
1. Role of non-classical renin-angiotensin system axis in renal fibrosis.
Lv LL; Liu BC
Front Physiol; 2015; 6():117. PubMed ID: 25954204
[TBL] [Abstract][Full Text] [Related]
2. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
Li XC; Zhang J; Zhuo JL
Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
[TBL] [Abstract][Full Text] [Related]
3. ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.
Simões E Silva AC; Teixeira MM
Pharmacol Res; 2016 May; 107():154-162. PubMed ID: 26995300
[TBL] [Abstract][Full Text] [Related]
4. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
5. Expression and Function of Mas-Related G Protein-Coupled Receptor D and Its Ligand Alamandine in Retina.
Zhu P; Verma A; Prasad T; Li Q
Mol Neurobiol; 2020 Jan; 57(1):513-527. PubMed ID: 31392515
[TBL] [Abstract][Full Text] [Related]
6. ACE and ACE2 in kidney disease.
Mizuiri S; Ohashi Y
World J Nephrol; 2015 Feb; 4(1):74-82. PubMed ID: 25664248
[TBL] [Abstract][Full Text] [Related]
7. Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options.
Rajapaksha IG; Gunarathne LS; Angus PW; Herath CB
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33670126
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system in the kidney: What is new?
Ferrão FM; Lara LS; Lowe J
World J Nephrol; 2014 Aug; 3(3):64-76. PubMed ID: 25332897
[TBL] [Abstract][Full Text] [Related]
9. Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System.
Nunes-Silva A; Rocha GC; Magalhaes DM; Vaz LN; Salviano de Faria MH; Simoes E Silva AC
Protein Pept Lett; 2017 Nov; 24(9):809-816. PubMed ID: 28758593
[TBL] [Abstract][Full Text] [Related]
10. The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research.
Rodrigues Prestes TR; Rocha NP; Miranda AS; Teixeira AL; Simoes-E-Silva AC
Curr Drug Targets; 2017; 18(11):1301-1313. PubMed ID: 27469342
[TBL] [Abstract][Full Text] [Related]
11. Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension.
Shim KY; Eom YW; Kim MY; Kang SH; Baik SK
Korean J Intern Med; 2018 May; 33(3):453-461. PubMed ID: 29462546
[TBL] [Abstract][Full Text] [Related]
12. Alamandine: a new member of the angiotensin family.
Villela DC; Passos-Silva DG; Santos RA
Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):130-4. PubMed ID: 24389733
[TBL] [Abstract][Full Text] [Related]
13. New frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms.
Zhuo JL; Ferrao FM; Zheng Y; Li XC
Front Endocrinol (Lausanne); 2013; 4():166. PubMed ID: 24273531
[TBL] [Abstract][Full Text] [Related]
14. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
15. Alternative Renin-Angiotensin System.
Bader M; Steckelings UM; Alenina N; Santos RAS; Ferrario CM
Hypertension; 2024 May; 81(5):964-976. PubMed ID: 38362781
[TBL] [Abstract][Full Text] [Related]
16. Update on the Angiotensin converting enzyme 2-Angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways.
Chappell MC; Marshall AC; Alzayadneh EM; Shaltout HA; Diz DI
Front Endocrinol (Lausanne); 2014 Jan; 4():201. PubMed ID: 24409169
[TBL] [Abstract][Full Text] [Related]
17. Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells.
Xue H; Zhou L; Yuan P; Wang Z; Ni J; Yao T; Wang J; Huang Y; Yu C; Lu L
Regul Pept; 2012 Aug; 177(1-3):12-20. PubMed ID: 22561449
[TBL] [Abstract][Full Text] [Related]
18. The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review.
Almeida-Santos AF; Kangussu LM; Campagnole-Santos MJ
Protein Pept Lett; 2017 Nov; 24(9):841-853. PubMed ID: 28828974
[TBL] [Abstract][Full Text] [Related]
19. The intrarenal renin-angiotensin system in hypertension.
Carey RM
Adv Chronic Kidney Dis; 2015 May; 22(3):204-10. PubMed ID: 25908469
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.
Santos RA; Ferreira AJ; Simões E Silva AC
Exp Physiol; 2008 May; 93(5):519-27. PubMed ID: 18310257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
